rs137853198
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_144573.4(NEXN):c.1831C>A(p.Pro611Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144573.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461590Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727108
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1CC Pathogenic:1
- -
Cardiovascular phenotype Uncertain:1
The p.P611T variant (also known as c.1831C>A), located in coding exon 12 of the NEXN gene, results from a C to A substitution at nucleotide position 1831. The proline at codon 611 is replaced by threonine, an amino acid with highly similar properties. This variant has been detected in an individual with dilated cardiomyopathy (DCM) (Hassel D et al. Nat Med, 2009 Nov;15:1281-8). Zebrafish embryos expressing the corresponding variant recapitulated DCM phenotype (Hassel D et al. Nat Med, 2009 Nov;15:1281-8). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at